:12pt">FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 15, 2020

 

UROGEN PHARMA LTD.

(Exact name of registrant as specified in its charter)

 

Israel

 

001-38079

 

98-1460746

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

© Acquiremedia - 2020